ArticleBritish journal of cancer2024

KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer.

Yingxi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.